Pulse Biosciences, Inc. Peo Total Comp Amt
Pulse Biosciences, Inc. (PLSE) reported Peo Total Comp Amt of $424.29 thousand for the 12-month period ending 2022-12-31, per its DEF 14A filed 2026-05-11.
Financial Statements › Notes
ecd:PeoTotalCompAmt · last filed 2026-05-11
| Period end | Peo Total Comp Amt 12 month |
|---|---|
| 2022-12-31 | $424.29K DEF 14A · filed 2026-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |